Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study-Reference-Cited by-同舟云学术

Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study

Published:2013-04 Issue:4 Volume:165 Page:515-522
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Montalescot Gilles,Lassen Jens Flensted,Hamm Christian W.,Lapostolle Frédéric,Silvain Johanne,ten Berg Jurriën M.,Cantor Warren J.,Goodman Shaun G.,Licour Muriel,Tsatsaris Anne,van't Hof Arnoud W.

Funder

AstraZeneca

Liz Anfield

Prime Medica Ltd

Knutsford

Cheshire

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators;Simes;Circulation,1995